See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
News Digest / StockInvest.us

Author: StockInvest.us
05:11pm, Tuesday, May 13, 2025
Verrica Pharmaceuticals Reports Improved Net Loss Despite Declining Revenue and Liquidity Concerns
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) presents its latest financial report for the quarter ended March 31, 2025. Financial Overview: Total Revenue: $3.439 million, down from $3.826 million in the same quarter of 2024. Product Revenue, Net: $3.422 million, a slight increase from $3.232 mill...
Read More